Prostatakræft

Michael Borre; John Brandt Brodersen; Henrik Jakobsen; Jimmi Søndergaard; Mads Hvid Aaberg Poulsen

Prostatakræft

Translated title of the contribution: Prostate cancer

Michael Borre^*, John Brandt Brodersen, Henrik Jakobsen, Jimmi Søndergaard, Mads Hvid Aaberg Poulsen

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

4 Downloads (Pure)

Abstract

This review investigates prostate cancer which with approx. 4,500 new cases annually is the most frequent male cancer, and the incidence is expected to increase due to demographic developments. Prostate cancer can have a natural history without progression to symptomatic or fatal disease, which is why overdiagnosis is one of the disease’s biggest challenges. In contrast to potential curable localized clinically significant disease, this is not the case after metastasis. Fortunately, new treatments, and not least combinations thereof, have increased both lifespan and quality of life in these patients significantly.

Translated title of the contribution	Prostate cancer
Original language	Danish
Article number	V10220588
Journal	Ugeskrift for Læger
Volume	185
Issue number	7A
ISSN	0041-5782
Publication status	Published - 3. Apr 2023

Documents & Links

Open Access VersionFinal published version, 730 KBLicence: CC BY-NC-ND

https://ugeskriftet.dk/videnskab/prostatakraeftLicence: CC BY-NC-ND

Cite this

@article{957fa0777ec64f7ea917d2300c509a05,

title = "Prostatakr{\ae}ft",

abstract = "This review investigates prostate cancer which with approx. 4,500 new cases annually is the most frequent male cancer, and the incidence is expected to increase due to demographic developments. Prostate cancer can have a natural history without progression to symptomatic or fatal disease, which is why overdiagnosis is one of the disease{\textquoteright}s biggest challenges. In contrast to potential curable localized clinically significant disease, this is not the case after metastasis. Fortunately, new treatments, and not least combinations thereof, have increased both lifespan and quality of life in these patients significantly.",

keywords = "Humans, Incidence, Male, Prostatic Neoplasms/diagnosis, Quality of Life",

author = "Michael Borre and Brodersen, {John Brandt} and Henrik Jakobsen and Jimmi S{\o}ndergaard and Poulsen, {Mads Hvid Aaberg}",

year = "2023",

month = apr,

day = "3",

language = "Dansk",

volume = "185",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "7A",

}

TY - JOUR

T1 - Prostatakræft

AU - Borre, Michael

AU - Brodersen, John Brandt

AU - Jakobsen, Henrik

AU - Søndergaard, Jimmi

AU - Poulsen, Mads Hvid Aaberg

PY - 2023/4/3

Y1 - 2023/4/3

N2 - This review investigates prostate cancer which with approx. 4,500 new cases annually is the most frequent male cancer, and the incidence is expected to increase due to demographic developments. Prostate cancer can have a natural history without progression to symptomatic or fatal disease, which is why overdiagnosis is one of the disease’s biggest challenges. In contrast to potential curable localized clinically significant disease, this is not the case after metastasis. Fortunately, new treatments, and not least combinations thereof, have increased both lifespan and quality of life in these patients significantly.

AB - This review investigates prostate cancer which with approx. 4,500 new cases annually is the most frequent male cancer, and the incidence is expected to increase due to demographic developments. Prostate cancer can have a natural history without progression to symptomatic or fatal disease, which is why overdiagnosis is one of the disease’s biggest challenges. In contrast to potential curable localized clinically significant disease, this is not the case after metastasis. Fortunately, new treatments, and not least combinations thereof, have increased both lifespan and quality of life in these patients significantly.

KW - Humans

KW - Incidence

KW - Male

KW - Prostatic Neoplasms/diagnosis

KW - Quality of Life

M3 - Tidsskriftartikel

C2 - 37057694

AN - SCOPUS:85152375084

SN - 0041-5782

VL - 185

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 7A

M1 - V10220588

ER -

Prostatakræft

Abstract

Documents & Links

Fingerprint

Cite this